Clinical Exmination. Guillain-Barre syndrome, CIDP.
|
Accession number;02A0539940
|
| Title;Clinical Exmination. Guillain-Barre syndrome, CIDP. |
| Author;
IIJIMA MASAHIRO
(Nagoya Univ.)
SOBUE GEN
(Nagoya Univ.)
|
Journal Title;Clinic All-round
|
Journal Code:Z0697A
|
ISSN:0371-1900
|
|
VOL.51;NO.;PAGE.1146-1150(2002)
|
| Figure&Table&Reference;TBL.2, REF.6 |
| Pub. Country;Japan |
| Language;Japanese |
| Abstract;Guillain-Barre syndrome (GBS) is the peripheral nerve disorder of acute and movement disorder superiority, and the autoimmunity mechanism is concerned in the background. Features are that there is the medical history of precedent infections such as cold and gastroenteritis in the cases of about 2/3 and that the neurological symptom appears after 1 - 3 weeks, etc.. Recently, the existence of acute axon type in which the axon is primarily damaged is shown, and the examination for the diagnosis becomes importance, because the function prognosis is bad. As examination finding, in chronic inflammation demyelinating polyradiculitis (CIDP), unlike GBS, the rise of anticancer gliocide antibody is not recognized. In CIDP with a M protein, there is the rise of anti-MAG antibody and anti-SGPG antibody. The following were arranged in the table : Anticancer gliocide antibody and clinical feature of GBS. |
|
|
|
Related Articles;
|
|
